CIBC Private Wealth Group’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$6.83K Buy
288
+175
+155% +$4.26K ﹤0.01% 2548
2025
Q3
$2.81K Hold
113
﹤0.01% 2678
2025
Q2
$2.6K Sell
113
-67
-37% -$1.55K ﹤0.01% 2585
2025
Q1
$3.91K Buy
180
+47
+35% +$1.09K ﹤0.01% 2525
2024
Q4
$2.78K Hold
133
﹤0.01% 2633
2024
Q3
$2.42K Sell
133
-141
-51% -$2.69K ﹤0.01% 2770
2024
Q2
$4.67K Sell
274
-288
-51% -$5.1K ﹤0.01% 2533
2024
Q1
$10.7K Buy
+562
New +$11.9K ﹤0.01% 2249

Other funds holding PRVA

CIBC Private Wealth Group's PRVA Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Privia Health (PRVA) stake by 155% in Q4 2025, buying an estimated $4.26K and bringing the position to 288 shares worth $6.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2548.

CIBC Private Wealth Group first reported a position in PRVA in Q1 2024 and has held it in 8 quarters since. The position peaked at $10.7K in Q1 2024. 276 funds tracked by Wall St. Rank hold PRVA as of Q4 2025.

  • CIBC Private Wealth Group held 288 shares of Privia Health worth $6.83K as of Q4 2025.
  • CIBC Private Wealth Group bought 175 Privia Health shares in Q4 2025, an estimated $4.26K.
  • Privia Health made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2548 holding.
  • CIBC Private Wealth Group first reported a position in Privia Health in Q1 2024 and has held it in 8 quarters since.
  • CIBC Private Wealth Group's Privia Health position peaked at $10.7K in Q1 2024.
  • 276 funds tracked by Wall St. Rank held Privia Health as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.